Roy Drissen

6PUBLICATIONS
12CO-AUTHORS
Innate immunityHaematologyHaematological tumoursMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 12, 2026
A mechanism to initiate emergency type 2 myelopoiesis.

Alexandre Fagnan, Cristina Di Genua, Yiran Meng

|May 01, 2023
Epigenetic programming defines haematopoietic stem cell fate restriction.

Yiran Meng, Joana Carrelha, Roy Drissen

|Jun 17, 2022
Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.

Theodore P Braun, Mariam Okhovat, Cody Coblentz

|Aug 16, 2020
Micro-environmental sensing by bone marrow stroma identifies IL-6 and TGFβ1 as regulators of hematopoietic ageing.

Simona Valletta, Alexander Thomas, Yiran Meng

|Dec 01, 2019
Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.

Theodore P Braun, Mariam Okhovat, Cody Coblentz

|May 26, 2019
Identification of two distinct pathways of human myelopoiesis.

Roy Drissen, Supat Thongjuea, Kim Theilgaard-Mönch

Pageof 1